在诊断出认知障碍或痴呆症后"掌控":一个随机对照试验
Miia Rahja1, Harry McNaughton2, Maria Crotty1,3
1Flinders University, College of Medicine and Public Health, Flinders Health and Medical Research Institute, Adelaide, South Australia, Australia.
The Gerontologist
|November 24, 2025
概括
该计划并没有改善轻度认知障碍或痴呆症患者的生活质量. 需要进一步的研究来确定自主指导计划对这一群体的有效性.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 自主指导的计划可以在重大健康事件发生后支持个人.
- 轻度认知障碍 (MCI) 和轻度痴呆症需要有效的支持性干预.
- 生活质量 (QoL) 是这些条件的关键结果指标.
研究的目的:
- 为了评估"接管"自主指导程序的有效性.
- 为了比较MCI或轻度痴呆症患者与生活方式教育对照组对 QoL 的"负责"的影响.
- 评估二次结果,包括情绪,希望和活动参与.
主要方法:
- 一个双臂,开放标签,随机对照试验在澳大利亚阿德莱德进行.
- 患有MCI或轻度痴呆症的参与者 (n=160) 被随机分配到"负责"干预或对照组.
- 主要结局是QoL,通过SF-36物理组件总结 (PCS) 三个月后的得分来衡量.
主要成果:
- 三个月后",负责"和对照组之间没有观察到PCS分数的显著差异.
- 采访表明,参与"接管"计划的参与者报告了更积极的未来前景.
- 报告中没有关于心理组件总结,希望或情绪等二次结果的显著改善.
结论:
- "承担责任"计划没有证明MCI或轻度痴呆症患者的身体健康相关的QoL有显著改善.
- 目前的证据不支持这种特定的自我指导计划对这一群体的适当性和有效性.
- 需要进一步的研究来开发和验证对认知障碍的有效自我指导干预措施.
相关概念视频
01:22Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772
01:30Dementia
498
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
498
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:30Cognitive Development During Adulthood
752
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
752